Salim Syed has been named a first place Institutional Investor All-America Research Team Rising Star for his investment reports and recommendations on large biotechnology stocks. The designation is part of Institutional Investor magazine’s respected annual survey of buy side investors. Their ranking of research talent is widely regarded as the definitive list of the year’s best analysts on Wall Street. 

To read the full story, check out Institutional Investor's Rising Stars of Wall Street Research.